Sign In
Buy OPRX
$6.05
-0.220 (-3.51%)
At Close: Jul 31, 2026
Bull Of The Day: OptimizeRX (OPRX)
04:01pm, Thursday, 31'st Jul 2025
This stock is reporting earnings next week and posting positive operating margins is going to be key.
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
09:40am, Thursday, 31'st Jul 2025
OptimizeRx OPRX is carving out a secure niche in the increasingly crowded HealthTech landscape, signaling a developing moat anchored in scale, data and execution. Over the previous two quarters, the
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
09:46am, Friday, 25'th Jul 2025
OptimizeRx posts 11% Q1 growth and rising EBITDA, but long-term momentum hinges on scaling subscriptions and margin mix gains.
Best Growth Stocks to Buy for July 22nd
10:25am, Tuesday, 22'nd Jul 2025
OPRX, ADRNY and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 22, 2025.
OptimizeRx: Stock Could Rise As Profitability Is Achieved
03:47pm, Friday, 18'th Jul 2025
I expect OptimizeRx to turn profitable in 2025, driven by strong double-digit revenue growth and reduced operating expenses. The company's proprietary AI-powered omnichannel platform connects over 2 m
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?
09:36am, Friday, 18'th Jul 2025
OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
07:30am, Thursday, 17'th Jul 2025
WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and e
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?
10:31am, Wednesday, 16'th Jul 2025
OPRX is growing faster with rising subscription revenues and strong pharma demand, while GDRX lags due to slower consumer growth.
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
09:06am, Friday, 11'th Jul 2025
OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.
Best Growth Stocks to Buy for July 9th
09:26am, Wednesday, 09'th Jul 2025
OPRX, EWCZ and QFIN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 9, 2025.
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
10:51am, Friday, 04'th Jul 2025
OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?
11:35am, Thursday, 03'rd Jul 2025
OPRX surged 69.3% in three months as rising contracted revenue and subscription gains boost confidence and guidance.
Best Growth Stocks to Buy for June 25th
08:46am, Wednesday, 25'th Jun 2025
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today June 25th:
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
07:30am, Tuesday, 24'th Jun 2025
WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
03:00am, Wednesday, 18'th Jun 2025
CANNES, France--(BUSINESS WIRE)-- #TV--Simulmedia announced a strategic partnership with OptimizeRx Corp. to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT).
